Ocumetics talks 1-month intraocular lens postop results

Executive Summary

• Ocumetics Technology Corp. reported encouraging one‑month safety and visual performance results for the first Group 1 patients treated with its accommodating intraocular lens.
• All evaluated patients achieved functional distance vision of 20/40 or better without glasses; early near‑vision performance was also positive with no reported complications.
• The company highlighted favorable surgical technique outcomes and a low incidence of adverse events, underscoring the potential of the lens to provide continuous, glasses‑free vision.

Key Details

• Study Cohort: First‑in‑human early feasibility study; results presented for Group 1 (initial patient cohort).
• Safety Findings: No intraocular lens‑related or surgery‑related adverse events reported within the first month post‑implantation.
• Surgical Technique: Implantation procedures were performed without complications, confirming ease of surgical delivery of the Ocumetics accommodating lens.
• Distance Vision: All patients achieved functional distance vision of 20/40 (or better) unaided at one month.
• Near‑Vision Performance: Early indications of near‑vision improvement observed; patients demonstrated functional near focus without glasses.
• Clinical Milestone: Company describes the results as a historic milestone for both Ocumetics and the broader ophthalmology field.
• Future Outlook: Management expects continued visual improvements as patients adapt over subsequent months; further data to be released as the trial progresses.

Notable Quotes

“The safety profile and visual outcomes we’re seeing at this early stage are what we hoped for, and we are excited to continue building momentum as the clinical trial progresses.” – Dean Burns, President & CEO

“After one month, initial patients are already achieving functional distance vision of 20/40 or better without glasses and are showing encouraging signs of near‑vision performance with no complications.” – Dr. Doyle Stulting, Chief Medical Officer

“Our vision has always been to restore natural, seamless vision across all distances… I believe we are only beginning to see the true potential of the Ocumetics accommodating intraocular lens.” – Dr. Garth Webb, Chief Scientist & Founder